www.alopeciaworld.com
I have received a lot of interest from others on here in my involvement with the Xeljanz trials at Yale.
I thought it would be nice for everyone if I documented my progress on here.
Xeljanz is a Jak3 inhibitor and is believed to work with alopecia by turning off the distress signal relayed by the hair follicle to the attacking immune system which is the cause of the hairs falling out. Xeljanz comes in a strength of 5mg per pill and a full box contains 60 tablets. The recommended dosage for arthritis is 1 tablet in the morning and another in the evening each day.
The trial is set in a series of stages and there are requirements before participating. These include monthly visits and blood tests every 2 weeks. Dr Brett King is absolutely fantastic and is an inspiration to me. His positivity and enthusiasm gives me the much needed hope I have craved for over a decade. I have been put on a low dose to start with which is 1 tablet every other day. My dosage has now been increased to 1 tablet every day and next month it could be increased to 2 tablets per day depending on the results.
I have completed my first month and have already noticed my alopecia has stabilised . I have not lost any existing hairs. In addition to this I have seen little hairs growing in my chest area as well as eyebrows. Fingers crossed! To date, I have experienced no side effects.
-----------------------------
Related Post on Alopecia World:
Tags:
but are we really sure topical xeljanz exists?. i thought because of the size of the molecule and its non water solubility feature, it couldnt be turned into a cream. Only ruxolitinib and barocitinib were the ones that could. So many people have talked about xeljanz cream that I am not sure anymore. Moreover all the news regarding topical forms of these jak inhibitors talk only about ruxoli or barocitinib
http://news.yale.edu/2015/12/09/research-news-yale-doctors-help-bal... do you mean this one? because in the four paragraph it says
" The drug, ruxolitinib, belongs to a class of medications called JAK inhibitors, which alter the immune system. King had previously used another oral JAK inhibitor, tofacitinib, to restore hair to a male patient with alopecia universalis in 2014, and other researchers have shown that oral ruxolitinib restores hair in this condition, too."
It's incredible...Where did you read this price?
ruxolitinib is approved in europe and costs around 1500 euro/56 pills of 5mg, 3000 euros for the 20 mg version, so the cream might cost a lot less here. are the pharmaceuticals just trying to get advantage of so many people in the us using private insurance companies ? in stark contrast with europe where generally almost everyone uses the public health system to cover their medications?
ps. Xeljanz miracle,we can delete our messages, but i think is good to leave them for the rest of the people here that thought it was xeljanz, there were a few of them i think
Any mention of products and services on Alopecia World is for informational purposes only; it does not imply a recommendation or endorsement by Alopecia World. Nor should any statement or representation on this site be construed as professional, medical or expert advice, or as pre-screened or endorsed by Alopecia World. Alopecia World is not responsible or liable for any of the views, opinions or conduct, online or offline, of any user or member of Alopecia World.
© 2025 Created by Alopecia World.
Powered by